Latest | F'cast | |
---|---|---|
Div Yield | 1.2% | |
Div Cover | 3.8 | |
Op Mrgn | 9.1% | |
ROCE | 8.2% |
Latest | F'cast | |
---|---|---|
P/E | 21.1 | |
PEG | 1.9 | |
Pr/Revenue | 0.5 | |
Pr/Book | 1.0 |
Latest | F'cast | |
---|---|---|
Revenue | 11.2% | |
PBT | 10.7% | |
EPS | 11.4% | |
DPS | 9.5% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 919.90 | (231.00) | (5.20)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1,106.20 | (1.90) | (7.10)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 1,198.50 | 3.90 | 4.20p | 54.5 | n/a | n/a | 0.50p | 0.2% |
31-Dec-23 | 1,359.00 | 34.60 | 7.90p | 28.5 | 0.3 | +88% | 2.10p | 0.9% |
31-Dec-24 | 1,511.20 | 38.30 | 8.80p | 25.6 | 2.3 | +11% | 2.30p | 1.0% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 1,602.99 | 164.68 | 10.91p | 17.0 | 0.7 | +24% | 2.95p | 0.0% |
31-Dec-26 | 1,688.97 | 192.45 | 16.05p | 11.6 | 0.2 | +47% | 4.19p | 0.0% |
31-Dec-27 | 1,789.28 | 218.59 | 21.03p | 8.8 | 0.3 | +31% | 5.26p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIR... | 09-Jun-2021 | 12:30 | GlobeNewswire NA |
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIR... | 08-Jun-2021 | 10:36 | GlobeNewswire NA |
Invesco Ltd.: Form 8.3 - Spire Healthcare Group ... | 07-Jun-2021 | 14:48 | GlobeNewswire NA |
No recent information was found.
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 186.00p |
Change Today | -0.014p |
% Change | -0.75 % |
52 Week High | 267.00 |
52 Week Low | 171.60 |
Volume | 168,950 |
Shares Issued | 399.39m |
Market Cap | £742.86m |
Strong Buy | 5 |
Buy | 2 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 8 |
Time | Volume / Share Price |
16:28 | 244 @ 186.00p |
16:28 | 124 @ 186.00p |
16:28 | 1 @ 186.00p |
16:28 | 287 @ 185.60p |
16:25 | 194 @ 185.80p |
CEO | Justin Ash |
CFO | Harbant Samra |
You are here: research